Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03006341 · ClinicalTrials.gov registry record
Validation of Predictors of OAC Initiation Using EMR Data
A clinical trial, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- 140,187
- Enrollment target
NCT03006341 is a clinical trial that has completed, run by Boehringer Ingelheim. The registered enrollment target is 140,187 participants.
The verdict
NCT03006341 has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- 140,187 participants
- Enrollment target
Study Summary
The objectives of this study are, first, to identify select clinical covariates from electronic medical records (EMR) that might be associated with initiation of oral anticoagulant medications (dabigatran or warfarin) in patients with non-valvular atrial fibrillation (NVAF) at risk for stroke; second, to quantify the association between EMR-based clinical characteristics and patterns of insurance claims; third, to assess the potential for unmeasured confounding in dabigatran vs warfarin comparative effectiveness and safety studies based on administrative claims databases.
Interventions
- DRUG Warfarin
- DRUG Dabigatran etexilate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140,187 participants |
| Start Date | 2017-02-28 |
| Est. Completion | 2017-05-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03006341
The ClinicalTrials.gov registry entry for NCT03006341 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 140,187 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boehringer Ingelheim, which has 515 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Warfarin is the first listed.
NCT03006341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03006341 about?
NCT03006341 is a clinical study titled "Validation of Predictors of OAC Initiation Using EMR Data". The objectives of this study are, first, to identify select clinical covariates from electronic medical records (EMR) that might be associated with initiation of oral anticoagulant medications (dabigatran or warfarin) in patients with non-valvular atrial fibrillation (NVAF) at risk for stroke; secon...
What is the current status of trial NCT03006341?
This trial is currently completed. The enrollment target is 140,187 participants. The study started on 2017-02-28. Estimated completion is 2017-05-09.
What interventions are being tested in trial NCT03006341?
The interventions under investigation include: Warfarin (DRUG), Dabigatran etexilate (DRUG).
Who is sponsoring clinical trial NCT03006341?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.